Helmy Eltoukhy holds significant stock in Guardant Health, reflecting his commitment to the company's future. In 2020, his total compensation was around $113.9 million, mostly from vested stock options due to the Founders’ Performance Awards he waived for several years....

Helmy Eltoukhy holds significant stock in Guardant Health, reflecting his commitment to the company's future. In 2020, his total compensation was around $113.9 million, mostly from vested stock options due to the Founders’ Performance Awards he waived for several years. By 2021, his compensation dramatically dropped to just $13,665 as he opted out from annual incentive plans, showing his focus on long-term vision over immediate gains. This was a sharp contrast to the previous year when he received substantial vested stock valued at $218.5 million. His approach is clear: align interests with the company's growth and success.